BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mustafa S, Bougie J, Miguelez M, Clerzius G, Rampakakis E, Proulx J, Malla A. Real-life assessment of aripiprazole monthly (Abilify Maintena) in schizophrenia: a Canadian naturalistic non-interventional prospective cohort study. BMC Psychiatry 2019;19:114. [PMID: 30991969 DOI: 10.1186/s12888-019-2103-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Shukla AK, Mehani R, Sadasivam B. Abilify MyCite (Aripiprazole): A Critical Evaluation of the Novel Dosage Form. J Clin Psychopharmacol 2021;41:93-4. [PMID: 33347031 DOI: 10.1097/JCP.0000000000001334] [Reference Citation Analysis]
2 Szota AM, Araszkiewicz A. The effectiveness of long-term aripiprazole injections to a patient with paranoid schizophrenia: a case report. Current Problems of Psychiatry 2020;21:154-60. [DOI: 10.2478/cpp-2020-0014] [Reference Citation Analysis]
3 Schöttle D, Janetzky W, Luedecke D, Beck E, Correll CU, Wiedemann K. The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing index. BMC Psychiatry 2020;20:77. [PMID: 32087718 DOI: 10.1186/s12888-020-02488-1] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pae CU, Han C, Bahk WM, Lee SJ, Patkar AA, Masand PS. Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study. Clin Psychopharmacol Neurosci 2021;19:233-42. [PMID: 33888652 DOI: 10.9758/cpn.2021.19.2.233] [Reference Citation Analysis]
5 Aftab R, Pereira M, Hewitt J, Whale R. Effectiveness and Predictors of Discontinuation of Aripiprazole Long-acting Injection: A 12-Month Naturalistic Cohort Study. J Clin Psychopharmacol 2021;41:478-83. [PMID: 34155164 DOI: 10.1097/JCP.0000000000001437] [Reference Citation Analysis]
6 Olivares JM, González-Pinto A, Páramo M; PROSIGO Study Group. Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study. Eur Psychiatry 2021;64:e40. [PMID: 33840396 DOI: 10.1192/j.eurpsy.2021.23] [Reference Citation Analysis]
7 Rognoni C, Bertolani A, Jommi C. Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects. Clin Drug Investig 2021;41:303-19. [PMID: 33686614 DOI: 10.1007/s40261-021-01000-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]